Showing results (71-80 of 206) with videos related to
Sort By:
Pageof 21
Bio-Protocol|March 4, 2021
Expression and Purification of Recombinant Skd3 (Human ClpB) Protein and Tobacco Etch Virus (TEV) Protease from Escherichia coliRyan R Cupo, James ShorterRare Diseases (Austin, Tex.)|July 9, 2014
Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assemblyJames Shorter, J Paul TaylorTrends in Genetics : TIG|February 8, 2021
Open Access: A Role for p53 in c9ALS/FTD?Charlotte M Fare, James ShorterBiochimica Et Biophysica Acta|August 17, 2011
The elusive middle domain of Hsp104 and ClpB: location and functionMorgan E Desantis, James ShorterCell|April 15, 2022
Flying under the radar: TMEM106B(120-254) fibrils break out in diverse neurodegenerative disordersKatie E Copley, James ShorterMbio|May 17, 2023
Probing the drivers of Staphylococcus aureus biofilm protein amyloidogenesis and disrupting biofilms with engineered protein disaggregasesMatthew K Howard, Karlie R Miller, Brian S Sohn, et al.Elife|December 15, 2020
Therapeutic genetic variation revealed in diverse Hsp104 homologsZachary M March, Katelyn Sweeney, Hanna Kim, et al.Molecular Cell|September 20, 2025
Matrin-3 forms spherical and wormlike assemblies that are modulated by RNA binding and ALS/FTD-associated mutationsMacy L Sprunger, Min Kyung Shinn, Sabrina K Talir, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 5, 2010
Applying Hsp104 to protein-misfolding disordersShilpa Vashist, Mimi Cushman, James ShorterBio-Protocol|March 4, 2021
Karyopherin-β2 Inhibits and Reverses Aggregation and Liquid-liquid Phase Separation of the ALS/FTD-Associated Protein FUSEmma Robinson, James Shorter, Lin GuoPageof 21